Results 1 to 10 of about 20,284 (182)

Association between CYP2C19 gene polymorphisms and Helicobacter pylori infection in Hainan region [PDF]

open access: yesBMC Infectious Diseases
Objective This study was to investigate CYP2C19 gene and their association with H. pylori infection in the region of Hainan. Methods We conducted CYP2C19 genotype analysis in Hainan.
Shimei Huang   +8 more
doaj   +2 more sources

In vitro assessment of the impact of 30 CYP2C19 variants on citalopram metabolism [PDF]

open access: yesPeerJ
Background CYP2C19 polymorphisms are correlated with individual variability in response to citalopram treatment. The pharmacogenomic testing of CYP2C19 has been shown to optimize the safety and efficacy of citalopram medication. Exploration of the effect
Peng Wang, Xiao-xia Hu, Jun-wei Li
doaj   +3 more sources

Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole

open access: yesClinical and Translational Science
Voriconazole is the cornerstone of the treatment and prevention of fungal infections. While there is a good correlation between CYP2C19 genotype and voriconazole exposure during prophylactic treatment, no correlation was found in patients with invasive ...
Sylvia D. Klomp   +6 more
doaj   +5 more sources

PharmVar GeneFocus: CYP2C19 [PDF]

open access: yesClinical Pharmacology & Therapeutics, 2020
The Pharmacogene Variation Consortium (PharmVar) catalogues star (*) allele nomenclature for the polymorphic human CYP2C19 gene. CYP2C19 genetic variation impacts the metabolism of many drugs and has been associated with both efficacy and safety issues for several commonly prescribed medications.
Botton, Mariana R.   +14 more
openaire   +2 more sources

Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse

open access: yesScientific Reports, 2021
CYP2C19*2 and CYP2C19*17 might influence tamoxifen metabolism and clinical outcome. Our aim was to investigate the effect of CYP2C19 genotypes on tamoxifen concentrations and metabolic ratios (MRs) and breast cancer recurrence in a large cohort of ...
A. B. Sanchez-Spitman   +5 more
doaj   +1 more source

Distribution of a novel CYP2C haplotype in Native American populations

open access: yesFrontiers in Genetics, 2023
The CYP2C19 gene, located in the CYP2C cluster, encodes the major drug metabolism enzyme CYP2C19. This gene is highly polymorphic and no-function (CYP2C19*2 and CYP2C19*3), reduced function (CYP2C19*9) and increased function (CYP2C19*17) star alleles ...
Vanessa Câmara Fernandes   +4 more
doaj   +1 more source

The impact of CYP2C19 genotype on phenoconversion by concomitant medication

open access: yesFrontiers in Pharmacology, 2023
Introduction: Pharmacogenetics-informed drug prescribing is increasingly applied in clinical practice. Typically, drug metabolizing phenotypes are determined based on genetic test results, whereupon dosage or drugs are adjusted.
Laura M. de Jong   +11 more
doaj   +1 more source

Evaluation of changes in cytochrome P450 2C19 activity in type 2 diabetic rats before and after treatment, by using isolated perfused liver model [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2020
Objective(s): Alteration in drug metabolism is very likely in diabetes mellitus. This study assessed changes in CYP2C19 enzymatic activity in the liver using omeprazole as a probe in the animal model of type II diabetes (T2DM) before and after treatment ...
Navid Neyshaburinezhad   +4 more
doaj   +1 more source

CYP2C19*1 and CYP2C19*2 Polymorphism in Turkish Patients Being Diagnosed with Stable Coronary Artery Disease and Using Clopidogrel

open access: yesBagcilar Medical Bulletin, 2021
Objective:The CYP2C19*1 has an entirely normal activity allele whose clopidogrel metabolism is normal. CYP2C19*2 called as non-functional alleles. In this study, we aimed to establish the CYP2C19*1 and CYP2C19*2 genotype frequencies both in Turkish ...
Ramazan Sabırlı   +3 more
doaj   +1 more source

Association of polymorphic variants of CYP2C19, P2RY12, ITGB3, ITGA2 and eNOS3 genes with high residual platelet reactivity while taking clopidogrel and acetylsalicylic acid at different terms of myocardial infarction

open access: yesРациональная фармакотерапия в кардиологии, 2023
Aim. Study of the association of polymorphic variants of CYP2C19 (G681A), P2RY12 (H1/H2), ITGB3 (T1565C), ITGA2 (C807T), eNOS3 (T786C) genes with high residual platelet reactivity (HRPR) to clopidogrel and acetylsalicylic acid (ASA) at different terms of
T. P. Pronko   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy